LPL Financial
OVID icon

LPL Financial’s Ovid Therapeutics OVID Stock Holding History

LPL Financial’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$154K Buy
69,548
+39,548
+132% +$70.7K ﹤0.01% 5580
2025
Q4 		$48.9K Buy
30,000
+18,000
+150% +$27.7K ﹤0.01% 5702
2025
Q3 		$15.6K Buy
+12,000
New +$10.4K ﹤0.01% 5753

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LPL Financial's OVID Position: Q1 2026 in Review

LPL Financial increased its Ovid Therapeutics (OVID) stake by 132% in Q1 2026, buying an estimated $70.7K and bringing the position to 69,548 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #5580.

LPL Financial first reported a position in OVID in Q3 2025 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • LPL Financial held 69,548 shares of Ovid Therapeutics worth $154K as of Q1 2026.
  • LPL Financial bought 39,548 Ovid Therapeutics shares in Q1 2026, an estimated $70.7K.
  • Ovid Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5580 holding.
  • LPL Financial first reported a position in Ovid Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.